ロード中...
“First-Wave” Bias When Conducting Active Safety Monitoring of Newly Marketed Medications with Outcome-Indexed Self-Controlled Designs
Large health care databases are used extensively for pharmacoepidemiologic studies. Unique methodological issues arise when applying self-controlled designs (i.e., using within-person comparisons) for active surveillance of newly marketed drugs. We use 3 examples to illustrate bias related to popula...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2014
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4215070/ https://ncbi.nlm.nih.gov/pubmed/25086050 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/aje/kwu162 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|